SecBot SecBot
144 ·Filed Nov 4, 2026

MIRM

Mirum Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 4h ago SEC0001670138-26-000007
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine sell-to-cover transaction for tax withholding on vested equity awards, not a discretionary insider sale. Monitor for any subsequent Form 4 filings to confirm the sale was executed, but no material signal for the stock.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$93.54
T+0 close · Nov 4, 2026 · via day close
Latest settled
−0.22%
T+5 · $93.33 · next T+20 in 17d
Vs SPY
−3.52%
α at T+5
Latest observation
−3.31%
T+7 · FF3 residual α
  1. T+0 · Nov 5 $93.54entry
  2. T+1 · 11d ago +0.19%α −0.12% · $93.72
  3. T+5 · 5d ago −0.22%α −3.52% · $93.33
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Joanne Quan, a former officer of Mirum Pharmaceuticals, filed a Form 144 to sell 14,684 shares of common stock with an approximate value of $1.42 million. The filing indicates the sale is a sell-to-cover transaction for taxes owed related to recent vesting of stock unit awards. The sale represents a small fraction of the company's $5.6B market cap and appears routine in nature.

Key Facts

  • Joanne Quan, a former officer, filed a Form 144 to sell 14,684 shares of Mirum common stock.
  • The approximate market value of the proposed sale is $1,423,907.48.
  • The filing states this is a sell-to-cover transaction for taxes owed related to recent vesting of stock unit awards.
  • The shares were acquired on 11/02/2026 via vesting of restricted stock units under a registered plan.
  • The proposed sale date is 11/04/2026, and the shares are listed on Nasdaq.
  • The sale represents about 0.02% of the company's $5.6B market cap.

Financial Impact

Proposed sale of 14,684 shares valued at approximately $1.42 million, representing a small fraction of the company's market cap.

dilution

Risk Factors

  • The sale may still be executed, but the disclosed purpose (tax withholding) reduces signaling value.
  • No other insider selling patterns or context provided to assess broader insider sentiment.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001670138-26-000007
Document: 0001670138-26-000007-index.html0001670138-26-000007
Document: 0001670138-26-000007.txt0001670138-26-000007

Track record

27 reports on MIRM

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +28.29% at T+20 after the Jun 11, 2026 report. 8 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 Now $91.58 −0.76% settles Feb 12
  2. Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 Now $91.58 −2.10% settles Feb 12
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 Now $91.58 −1.88% settles Feb 10
  4. Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 Now $91.58 −3.01% settles Feb 8
  5. Nov 4, 202612d ago 144 Neutral 2/10 Viewing Entry $93.54 Now $91.58 −2.10% settles Feb 3
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
  7. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 Now $91.58 −5.56% settles Feb 2
  8. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 Now $91.58 +6.72% settles Jan 26
  9. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 Now $91.58 +7.04% settles Jan 25
  10. Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 Now $91.58 +15.02% settles Jan 8
Showing 10 of 27

US Market Status

Market Closed · Opens in 8h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026